3001 - 3050 of 8808 Results
Title
Year
-
OPENTitle: Characterization and diagnostic potential of R2* in early-stage progressive supranuclear palsy variantsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 101Issue #:Start Page: 43End Page: 48Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.021Best OA location URL: http://www.prd-journal.com/article/S1353802022002176/pdfCitation Count: 10
-
OPENTitle: Polygenic burden of Parkinson's disease risk stratifies the prognosis of isolated rapid-eye-movement disorder: A preliminary observational studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 96Issue #:Start Page: 52End Page: 56Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.02.005Best OA location URL: https://doi.org/10.1016/j.parkreldis.2022.02.005Citation Count: 2
-
RESTRICTEDTitle: Association between probable REM sleep behavior disorder and increased dermal alpha-synuclein deposition in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 99Issue #:Start Page: 58End Page: 61Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.05.010Citation Count: 16
-
OPENTitle: What the VaP? The meaning of “vascular parkinsonism”Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 94Issue #:Start Page: 132End Page: 134Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.12.008Citation Count: 7
-
OPENTitle: The effect of limb selection methods on gait analysis in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 104Issue #:Start Page: 81End Page: 84Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.10.013Citation Count: 2
-
OPENTitle: Smoking is associated with age at disease onset in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 97Issue #:Start Page: 79End Page: 83Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.03.005Citation Count: 5
-
RESTRICTEDTitle: Serial olfactory testing for the diagnosis of prodromal Parkinson's disease in the PARS studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 104Issue #:Start Page: 15End Page: 20Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.09.007Citation Count: 8
-
OPENTitle: Physical activity and exercise outcomes in Huntington's disease (PACE-HD): results of a 12-month trial-within-cohort feasibility study of a physical activity intervention in people with Huntington's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 101Issue #:Start Page: 75End Page: 89Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.013Best OA location URL: http://www.prd-journal.com/article/S1353802022002048/pdfCitation Count: 15
-
OPENTitle: Relationships of self-reported and objective measures of sleep, sleepiness, and sleep quality in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 101Issue #:Start Page: 57End Page: 61Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.009Citation Count: 8
- Predictors of multi-domain cognitive decline following DBS for treatment of Parkinson's disease2021RESTRICTEDTitle: Predictors of multi-domain cognitive decline following DBS for treatment of Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 95Issue #:Start Page: 23End Page: 27Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.12.011Citation Count: 12
-
RESTRICTEDTitle: L-Dopa response, choreic dyskinesia, and dystonia in Perry syndromeJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 100Issue #:Start Page: 19End Page: 23Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.05.023Citation Count: 7
-
RESTRICTEDTitle: Pallidal neuronal activity in multiple system atrophy type P and Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 101Issue #:Start Page: 15End Page: 17Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.007Citation Count: 1
-
RESTRICTEDTitle: Droxidopa reduces postural sway in Parkinson disease patients with orthostatic hypotensionJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 99Issue #:Start Page: 62End Page: 64Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.05.002Citation Count: 3
-
OPENTitle: Minimal clinically important change in Abnormal Involuntary Movement Scale score in tardive dyskinesia as assessed in pivotal trials of deutetrabenazineJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 97Issue #:Start Page: 47End Page: 51Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.02.017Best OA location URL: https://doi.org/10.1016/j.parkreldis.2022.02.017Citation Count: 7
-
RESTRICTEDTitle: The plight of loneliness in Parkinson's disease: New opportunitiesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 105Issue #:Start Page: 145End Page: 148Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.10.029Citation Count: 5
-
OPENTitle: Amyloid β, Tau, and α-Synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseasesJournal Name: Progress in NeurobiologyPublisher: Elsevier BVVol: 214Issue #:Start Page: 102270End Page: 102270Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.pneurobio.2022.102270Best OA location URL: https://doi.org/10.1016/j.pneurobio.2022.102270Citation Count: 217
-
RESTRICTEDTitle: Une valine 11 codée par le gène HLA-DRB1 est associée inversement au risque de maladie de Parkinson et interagit avec l’initiation du tabagismeJournal Name: Revue NeurologiquePublisher: Elsevier BVVol: 178Issue #:Start Page: S15End Page: S15Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurol.2022.02.151Citation Count: 0
-
RESTRICTEDTitle: La thérapie comportementale et cognitive pour l’anxiété dans la maladie de Parkinson induit des modifications cérébrales fonctionnellesJournal Name: Revue NeurologiquePublisher: Elsevier BVVol: 178Issue #:Start Page: S15End Page: S15Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurol.2022.02.152Citation Count: 0
- The protean roles of neuroinflammation in trauma, infections, autoimmunity and neurodegeneration2022RESTRICTEDTitle: The protean roles of neuroinflammation in trauma, infections, autoimmunity and neurodegenerationJournal Name: Seminars in ImmunologyPublisher: Elsevier BVVol: 61-64Issue #:Start Page: 101655End Page: 101655Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.smim.2022.101655Citation Count: 3
-
OPENTitle: Non-REM sleep with hypertonia in Parkinsonian Spectrum Disorders: A pilot investigationJournal Name: Sleep MedicinePublisher: Elsevier BVVol: 100Issue #:Start Page: 501End Page: 510Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.sleep.2022.09.025Best OA location URL: https://escholarship.org/uc/item/782393zzCitation Count: 12
-
OPENTitle: An economic evaluation of the NightWatch for children with refractory epilepsy: Insight into the cost-effectiveness and cost-utilityJournal Name: Seizure: European Journal of EpilepsyPublisher: Elsevier BVVol: 101Issue #:Start Page: 156End Page: 161Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.seizure.2022.08.003Best OA location URL: http://www.seizure-journal.com/article/S1059131122001820/pdfCitation Count: 7
-
OPENTitle: Llamanade: An open-source computational pipeline for robust nanobody humanizationJournal Name: StructurePublisher: Elsevier BVVol: 30Issue #: 3Start Page: 418End Page: 429.e3Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.str.2021.11.006Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11698024Citation Count: 32
-
OPENTitle: Symptom Severity Mixity in Older-Age Bipolar Disorder: Analyses From the Global Aging and Geriatric Experiments in Bipolar Disorder Database (GAGE-BD)Journal Name: The American Journal of Geriatric PsychiatryPublisher: Elsevier BVVol: 30Issue #: 10Start Page: 1096End Page: 1107Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.jagp.2022.03.007Best OA location URL: https://escholarship.org/uc/item/38k068zmCitation Count: 17
-
OPENTitle: Apathy as a Within-Person Mediator of Depressive Symptoms and Cognition in Parkinson's Disease: Longitudinal Mediation AnalysesJournal Name: The American Journal of Geriatric PsychiatryPublisher: Elsevier BVVol: 30Issue #: 6Start Page: 664End Page: 674Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jagp.2021.11.007Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9106826Citation Count: 14
-
RESTRICTEDTitle: Inconsistency and incongruence: the two diagnostic pillars of functional movement disorderJournal Name: The LancetPublisher: Elsevier BVVol: 400Issue #: 10348Start Page: 328End Page: 328Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s0140-6736(22)01184-9Citation Count: 7
-
OPENTitle: Artificial intelligence for detection of Alzheimer's disease: demonstration of real-world value is required to bridge the translational gapJournal Name: The Lancet Digital HealthPublisher: Elsevier BVVol: 4Issue #: 11Start Page: e768End Page: e769Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/s2589-7500(22)00190-xBest OA location URL: http://www.thelancet.com/article/S258975002200190X/pdfCitation Count: 2
-
OPENTitle: Cholinergic system changes in Parkinson's disease: emerging therapeutic approachesJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 21Issue #: 4Start Page: 381End Page: 392Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00377-xBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8985079Citation Count: 220
-
RESTRICTEDTitle: Movement disorders research in 2021: cracking the paradigmJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 21Issue #: 1Start Page: 10End Page: 11Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00413-0Citation Count: 18
-
RESTRICTEDTitle: Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trialJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 21Issue #: 12Start Page: 1099End Page: 1109Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(22)00400-8Citation Count: 145
-
RESTRICTEDTitle: Revisiting levodopa for advanced Parkinson's diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 21Issue #: 12Start Page: 1063End Page: 1065Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(22)00435-5Citation Count: 1
-
RESTRICTEDTitle: Major advances in Parkinson's disease over the past two decades and future research directionsJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 21Issue #: 12Start Page: 1076End Page: 1079Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(22)00448-3Citation Count: 13
-
OPENTitle: Prevalence of parkinsonism and Parkinson disease in urban and rural populations from Latin America: A community based studyJournal Name: The Lancet Regional Health - AmericasPublisher: Elsevier BVVol: 7Issue #:Start Page: 100136End Page: 100136Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.lana.2021.100136Best OA location URL: https://doi.org/10.1016/j.lana.2021.100136Citation Count: 38
-
OPENTitle: Brain health: The hidden casualty of a humanitarian crisisJournal Name: The Lancet Regional Health - EuropePublisher: Elsevier BVVol: 15Issue #:Start Page: 100374End Page: 100374Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.lanepe.2022.100374Best OA location URL: https://doi.org/10.1016/j.lanepe.2022.100374Citation Count: 5
-
OPENTitle: Safety, tolerability and pharmacokinetics of the oligomer modulator anle138b with exposure levels sufficient for therapeutic efficacy in a murine Parkinson model: A randomised, double-blind, placebo-controlled phase 1a trialJournal Name: eBioMedicinePublisher: Elsevier BVVol: 80Issue #:Start Page: 104021End Page: 104021Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.ebiom.2022.104021Best OA location URL: http://www.thelancet.com/article/S2352396422002055/pdfCitation Count: 61
-
OPENTitle: Immune aging in multiple sclerosis is characterized by abnormal CD4 T cell activation and increased frequencies of cytotoxic CD4 T cells with advancing ageJournal Name: eBioMedicinePublisher: Elsevier BVVol: 82Issue #:Start Page: 104179End Page: 104179Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.ebiom.2022.104179Best OA location URL: http://www.thelancet.com/article/S2352396422003607/pdfCitation Count: 33
-
OPENTitle: The role of primary and secondary delays in the effective resonance frequency of acoustically interacting microbubblesJournal Name: Ultrasonics SonochemistryPublisher: Elsevier BVVol: 86Issue #:Start Page: 106033End Page: 106033Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.ultsonch.2022.106033Best OA location URL: https://doi.org/10.1016/j.ultsonch.2022.106033Citation Count: 16
-
OPENTitle: Whole genome sequencing identifies candidate genes for familial essential tremor and reveals biological pathways implicated in essential tremor aetiologyJournal Name: eBioMedicinePublisher: Elsevier BVVol: 85Issue #:Start Page: 104290End Page: 104290Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.ebiom.2022.104290Best OA location URL: http://www.thelancet.com/article/S2352396422004728/pdfCitation Count: 22
-
OPENTitle: Tailoring Motor Fluctuation Treatment: Beyond Levodopa Dose AdjustmentJournal Name: European Medical JournalPublisher: European Medical GroupVol:Issue #:Start Page: 20End Page: 27Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.33590/emj/10022165Best OA location URL: https://www.emjreviews.com/wp-content/uploads/2022/12/Tailoring-Motor-Fluctuation-Treatment-Beyond-Levodopa-Dose-Adjustment-1.pdfCitation Count: 0
-
OPENTitle: Botulinum Toxin in the Treatment of Cervical Dystonia: Evidence-Based ReviewJournal Name: DystoniaPublisher: Frontiers Media SAVol: 1Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/dyst.2022.10655Best OA location URL: https://www.frontierspartnerships.org/articles/10.3389/dyst.2022.10655/pdfCitation Count: 6
-
OPENTitle: Tele-Yoga for the Management of Cervical Dystonia: A Safety and Feasibility TrialJournal Name: DystoniaPublisher: Frontiers Media SAVol: 1Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/dyst.2021.10015Best OA location URL: https://www.frontierspartnerships.org/articles/10.3389/dyst.2021.10015/pdfCitation Count: 0
-
OPENTitle: The Role of Alpha-Synuclein Autoantibodies in the Induction of Brain Inflammation and Neurodegeneration in Aged HumansJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.902191Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2022.902191/pdfCitation Count: 7
-
OPENTitle: Editorial: Non-neuronal cell heterogeneity in the nervous system during health and diseaseJournal Name: Frontiers in Cellular NeurosciencePublisher: Frontiers Media SAVol: 16Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.3389/fncel.2022.1047296Best OA location URL: https://www.frontiersin.org/articles/10.3389/fncel.2022.1047296/pdfCitation Count: 1
-
OPENTitle: Editorial: Digital Innovation and Data-Driven Research in Neurodegenerative DiseasesJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.961847Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.961847/pdfCitation Count: 0
-
OPENTitle: Editorial: Cannabinoids in neuroinflammation, neurodegeneration and pain: Focus on non-neuronal cellsJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 16Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2022.1114775Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2022.1114775/pdfCitation Count: 1
-
OPENTitle: Editorial: LRRK2—Fifteen Years From Cloning to the ClinicJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 16Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2022.880914Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2022.880914/pdfCitation Count: 1
-
OPENTitle: Presenilin‐1 mutation position influences amyloidosis, small vessel disease, and dementia with disease stageJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 20Issue #: 4Start Page: 2680End Page: 2697Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/alz.13729Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.13729Citation Count: 5
-
OPENTitle: Cholinergic Nucleus 4 Degeneration and Cognitive Impairment in Isolated Rapid Eye Movement Sleep Behavior DisorderJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 3Start Page: 474End Page: 479Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29306Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29306Citation Count: 14
-
RESTRICTEDTitle: Differences in Sex‐Specific Frequency of Glucocerebrosidase Variant Carriers and Familial ParkinsonismJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 4Start Page: 714End Page: 715Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29353Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10501730/pdf/nihms-1871586.pdfCitation Count: 3
-
OPENTitle: Why Therapeutic Trials Fail in Primary TauopathiesJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 4Start Page: 545End Page: 550Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.29322Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10398638/pdf/nihms-1915318.pdfCitation Count: 5
-
OPENTitle: Duodenal alpha‐Synuclein Pathology and Enteric Gliosis in Advanced Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 5Start Page: 885End Page: 894Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29358Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29358Citation Count: 34